Peptide Sciences USA
Vesugen 20 mg
- Active Substance: Vesugen
- Concentration: 20 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Vesugen
- Molecular Formula: Not disclosed (custom cytogenetic peptide blend)
- Molecular Weight: Varies – proprietary peptide complex
- Sequence: Tissue-specific peptide chains derived from vascular DNA
- Synonyms: Vesilute (alternate branding), Vascular Cytogenetic Peptide
Vesugen 20 mg is a cytogenetic peptide bioregulator derived from short amino acid sequences that mimic vascular endothelial DNA. Produced by Peptide Sciences USA, Vesugen is studied for its ability to support vascular tissue integrity, improve microcirculation, and restore gene expression patterns related to aging. It belongs to a class of peptides known for their organ-targeted action and has shown promise in age-related degenerative models.
Mechanism of Action
Vesugen is believed to work by directly influencing gene transcription within vascular endothelial cells. It binds to the chromatin structures and promotes normalized expression of key regulatory genes, enhancing the structural and functional integrity of blood vessels. This includes stimulation of ribosomal and mitochondrial RNA synthesis, essential for protein generation and cellular repair.
In preclinical studies, Vesugen demonstrates the ability to reduce endothelial inflammation, improve microvascular elasticity, and combat oxidative stress markers. These mechanisms make it particularly useful in research models of cardiovascular aging, atherosclerosis, and systemic inflammation. Its cytogenetic profile allows it to target vascular tissue with precision, much like other peptides in the Khavinson group, including Pinealon and Thymalin.
Key Features & Benefits
- Vascular Health Research: Studied for supporting endothelial repair, vessel elasticity, and circulation improvement.
- Anti-Aging Peptide: Supports DNA expression associated with youthful cell function and vascular rejuvenation.
- Bioregulation of Gene Activity: Modulates transcription and protein synthesis pathways in endothelial cells.
- Purity & Reliability: Provided by Peptide Sciences USA with strict manufacturing standards for research use.
- Cellular Protection: Explored for reducing oxidative stress and inflammation in vascular tissues.
Legal Disclaimer
Disclaimer: Vesugen is a research-use-only peptide. It has not been approved for medical or therapeutic use. All studies should be performed in a licensed research facility with proper safety and handling protocols.
Frequently Asked Questions
Vesugen is studied for supporting vascular integrity, enhancing endothelial cell function, and modulating gene expression related to aging and inflammation.
In preclinical research settings, Vesugen has not demonstrated significant adverse effects, but it is not approved for human consumption and should be used with care in lab environments.
No, Pinealon and Vesugen are distinct cytogenetic peptides. Pinealon targets neural tissues for cognitive and brain-related studies, while Vesugen focuses on vascular health and endothelial regulation.
Related Products
